16^th World Heart Congress

Welcome Message

Welcome to the 16th World Heart Congress, taking place on March 18–19, 2027, in the vibrant city of Paris, France. This premier event brings together cardiologists, researchers, healthcare professionals, and industry leaders from around the world to share the latest advances and innovations in cardiovascular medicine. Over two days, attendees will have the opportunity to engage with cutting-edge research, exchange clinical expertise, and foster collaborations that drive the future of heart health.

Join us in this unique gathering to explore breakthrough therapies, emerging technologies, and preventive strategies that are shaping cardiovascular care globally. Whether you are a seasoned expert or an emerging professional, the congress offers a dynamic platform to learn, network, and contribute to the shared mission of improving cardiovascular health and enhancing patient care worldwide.

About Conference

The 16th World Heart Congress will be held on March 18–19, 2027, in the beautiful city of Paris, France. Continuing the success of previous editions, this internationally recognized congress will bring together leading cardiologists, cardiovascular researchers, clinicians, healthcare professionals, academicians, and industry experts to discuss the latest developments in heart health and cardiovascular medicine. The congress aims to encourage scientific exchange, promote innovation, and strengthen global collaborations to improve cardiovascular outcomes worldwide.

Cardiovascular diseases remain one of the greatest public health challenges worldwide. The congress provides a unique platform to explore recent advances in prevention, diagnosis, treatment, rehabilitation, and patient care. Through keynote presentations, scientific sessions, panel discussions, oral and poster presentations, workshops, and networking opportunities, participants will gain valuable knowledge from internationally recognized experts while exchanging ideas that inspire future discoveries.

The scientific program will highlight emerging topics such as preventive cardiology, cardiac imaging, interventional cardiology, heart failure management, electrophysiology, structural heart disease, artificial intelligence in cardiovascular medicine, digital health, wearable technologies, regenerative therapies, precision cardiology, and lifestyle interventions. Participants will also examine how innovative technologies and multidisciplinary collaboration are transforming the future of cardiovascular healthcare.

Beyond the scientific sessions, the congress offers outstanding opportunities to build professional relationships with experts from around the world, establish research collaborations, and exchange clinical experiences. Young investigators, early-career professionals, and students are encouraged to present their research, receive expert feedback, and contribute to the advancement of cardiovascular science.

The 16th World Heart Congress in Paris promises to be a landmark international event, bringing together science, innovation, education, and collaboration to advance cardiovascular medicine and improve heart health across the globe.

Who Should Attend?

Heart Congress 2027 welcomes cardiologists, surgeons, researchers, healthcare professionals, educators, industry leaders, policymakers, students, and trainees. The congress provides an international platform to exchange knowledge, establish collaborations, and explore innovations that advance cardiovascular medicine and improve patient outcomes worldwide.

Target Audience

1. Cardiologists and Cardiac Surgeons

2. Interventional Cardiologists

3. Cardiovascular Researchers

4. Cardiac Nurses and Technicians

5. Medical Educators and Faculty

6. Students and Trainees

7. Pharmaceutical and Biotechnology Professionals

8. Medical Device Engineers

9. Public Health Professionals

10. Clinical Trial Coordinators and Managers

11. Cardiac Rehabilitation Specialists

12. Digital Health and Health IT Experts

13. Nutritionists and Lifestyle Medicine Specialists

14. Emergency Medicine Physicians

15. Primary Care Physicians

16. Healthcare Policymakers and Regulators

17. Hospital Executives and Administrators

18. Biomedical Scientists

19. Cardiac Imaging Specialists

Why Attend the 16th World Heart Congress

The 16th World Heart Congress, taking place on March 18–19, 2027, in Paris, France, offers an exceptional opportunity for professionals committed to advancing cardiovascular medicine. This prestigious international congress brings together world-renowned experts, clinicians, researchers, innovators, and healthcare leaders to discuss the latest scientific discoveries and clinical advances in cardiology.

1. Explore the Latest Scientific Discoveries

• Learn about ground breaking research in cardiovascular medicine.

• Discover advances in clinical practice and patient management.

• Explore innovative technologies, therapies, and medical devices.

2. Comprehensive Scientific Sessions

• Inspiring keynote lectures by internationally recognized experts.

• Interactive panel discussions on emerging cardiovascular challenges.

• Practical workshops focused on advanced clinical skills.

• Poster and oral presentations featuring innovative research.

3. Global Networking Opportunities

• Meet leading experts from academia, hospitals, and industry.

• Build international collaborations for research and education.

• Expand your professional network with global healthcare leaders.

4. Address Current and Future Challenges

• Discuss the global burden of cardiovascular disease.

• Share evidence-based clinical practices and innovative solutions.

• Exchange multidisciplinary perspectives from healthcare systems worldwide.

5. Advance Your Professional Career

• Stay updated with emerging trends in cardiovascular medicine.

• Gain international exposure through scientific participation.

• Contribute to global efforts aimed at improving cardiovascular health and patient care.

Don't miss this outstanding opportunity to join the global cardiovascular community. Participate in the 16th World Heart Congress in Paris, France, to share knowledge, discover innovations, strengthen collaborations, and help shape the future of cardiovascular medicine. Register today and become part of the next generation of excellence in heart health.

Sessions & Tracks

Track 01 - Preventive Cardiology and Cardiovascular Risk Management

Preventive cardiology focuses on reducing the burden of cardiovascular disease through early detection, risk assessment, and lifestyle modification. Controlling hypertension, diabetes, obesity, smoking, and dyslipidemia significantly lowers the incidence of heart attacks and stroke. Advances in preventive strategies continue to improve long-term cardiovascular health.

• Cardiovascular risk assessment

• Hypertension and lipid management

• Lifestyle modification and prevention

• Population-based prevention strategies

Track 02 - Interventional Cardiology and Cardiac Catheterization

Interventional cardiology utilizes minimally invasive catheter-based procedures to diagnose and treat cardiovascular diseases. Technological advances have improved the safety and effectiveness of coronary interventions, structural heart procedures, and complex vascular treatments while reducing recovery time.

• Coronary angioplasty and stenting

• Structural heart interventions

• Advanced catheter-based procedures

• Innovation in interventional devices

Track 03 - Heart Failure and Cardiomyopathies

Heart failure remains a major cause of hospitalization and mortality worldwide. Modern therapies, advanced imaging, and multidisciplinary care have significantly improved diagnosis and patient outcomes for both inherited and acquired cardiomyopathies.

• Acute and chronic heart failure

• Dilated and hypertrophic cardiomyopathy

• Advanced heart failure therapies

• Mechanical circulatory support

Track 04 - Coronary Artery Disease and Acute Coronary Syndromes

Coronary artery disease continues to be one of the leading causes of death globally. Early diagnosis, rapid intervention, and evidence-based management improve survival and reduce long-term complications following myocardial infarction.

• Acute myocardial infarction

• Stable and unstable angina

• Coronary revascularization

• Secondary prevention strategies

Track 05 - Cardiac Imaging and Diagnostic Technologies

Modern imaging technologies play an essential role in diagnosing cardiovascular diseases. Echocardiography, CT, MRI, nuclear imaging, and AI-assisted diagnostics enable accurate assessment of cardiac structure, function, and disease progression.

• Echocardiography and Doppler imaging

• Cardiac CT and MRI

• Nuclear cardiology

• Artificial intelligence in imaging

Track 06 - Cardiac Electrophysiology and Arrhythmias

Electrophysiology focuses on the diagnosis and treatment of abnormal heart rhythms. Advances in mapping technologies, catheter ablation, and implantable devices continue to improve patient safety and clinical outcomes.

• Atrial fibrillation management

• Catheter ablation techniques

• Cardiac pacing

• Sudden cardiac death prevention

Track 07 - Structural Heart Disease and Valve Disorders

Structural heart disease includes congenital and acquired abnormalities affecting heart valves and chambers. Emerging transcatheter therapies have expanded treatment options for patients with complex structural heart conditions.

• Aortic and mitral valve disease

• Transcatheter valve replacement

• Congenital heart defects

• Structural heart interventions

Track 08 - Pediatric and Congenital Cardiology

Pediatric cardiology addresses cardiovascular disorders affecting infants, children, and adolescents. Early diagnosis and advances in surgical and interventional techniques continue to improve survival and quality of life.

• Congenital heart disease

• Pediatric cardiac surgery

• Fetal cardiology

• Lifelong congenital heart care

Track 09 - Cardiometabolic Health and Diabetes

Cardiometabolic disorders significantly increase cardiovascular risk. Integrated management of obesity, diabetes, hypertension, and metabolic syndrome is essential for preventing cardiovascular complications.

• Diabetes and cardiovascular disease

• Obesity management

• Metabolic syndrome

• Cardiovascular risk reduction

Track 10 - Cardio-Oncology

Cardio-oncology focuses on preventing, diagnosing, and treating cardiovascular complications associated with cancer therapies. Collaborative care improves outcomes for cancer patients with cardiovascular disease.

• Chemotherapy-induced cardiotoxicity

• Radiation-associated heart disease

• Cardiovascular monitoring

• Long-term survivorship care

Track 11 - Cardiovascular Surgery and Transplantation

Cardiovascular surgery remains essential for treating advanced heart disease. Innovations in minimally invasive surgery, robotic procedures, and transplantation continue to improve patient survival.

• Coronary artery bypass surgery

• Heart valve surgery

• Heart transplantation

• Mechanical circulatory support

Track 12 - Digital Cardiology and Artificial Intelligence

Digital technologies and artificial intelligence are transforming cardiovascular medicine through improved diagnostics, predictive analytics, remote monitoring, and personalized patient care.

• AI-assisted diagnosis

• Wearable cardiovascular devices

• Telecardiology

• Big data in cardiovascular medicine

Track 13 - Vascular Medicine and Pulmonary Hypertension

Vascular disorders and pulmonary hypertension contribute significantly to cardiovascular morbidity. Early diagnosis and targeted therapies improve patient outcomes and quality of life.

• Pulmonary arterial hypertension

• Peripheral arterial disease

• Venous thromboembolism

• Vascular imaging

Track 14 - Regenerative Cardiology and Precision Medicine

Regenerative medicine offers promising approaches for repairing damaged cardiac tissue through stem cells, gene therapy, tissue engineering, and precision-based treatment strategies.

• Stem cell therapy

• Cardiac tissue engineering

• Gene-based therapies

• Personalized cardiovascular medicine

Track 15 - Emerging Research and Future Trends in Cardiology

Rapid advances in cardiovascular research continue to reshape clinical practice. This track highlights innovative discoveries, novel therapeutics, translational research, and future directions in cardiovascular medicine.

• Clinical trials and translational research

• Precision cardiovascular care

• Novel therapeutic approaches

• Future innovations in cardiology

Market Analysis

The global cardiovascular health market is experiencing remarkable growth, driven by the increasing prevalence of cardiovascular diseases (CVDs), rising healthcare awareness, and continuous advancements in medical research and technology. As the 16th World Heart Congress brings together leading cardiologists, researchers, healthcare professionals, and industry innovators, understanding the current trends and future opportunities within the cardiovascular market is essential for advancing heart care worldwide.

The cardiovascular health industry has expanded significantly due to factors such as an aging global population, increasing rates of hypertension, diabetes, obesity, and lifestyle-related risk factors. Pharmaceutical innovations continue to play a vital role in cardiovascular treatment, with advancements in therapies for heart failure, cholesterol management, hypertension, anticoagulation, and arrhythmia control. At the same time, the medical device sector is witnessing rapid development through innovations in pacemakers, implantable cardioverter-defibrillators (ICDs), stents, transcatheter heart valves, and advanced monitoring technologies. Diagnostic advancements, including cardiac imaging systems, biomarker testing, and AI-supported diagnostic tools, are improving early detection and personalized cardiovascular care.

Regionally, North America continues to hold a significant position in the cardiovascular market due to advanced healthcare systems, strong research capabilities, and increased investment in innovative therapies. Europe remains a key contributor with a focus on healthcare innovation, clinical research, and improved cardiovascular disease prevention strategies. Meanwhile, the Asia-Pacific region is projected to experience substantial growth due to increasing healthcare investments, rising cardiovascular disease prevalence, expanding medical infrastructure, and growing demand for advanced treatment options.

Major trends shaping the future of cardiovascular healthcare include the rapid adoption of digital health solutions, wearable monitoring devices, and remote patient management technologies. Artificial intelligence, machine learning, precision medicine, and predictive analytics are transforming cardiovascular diagnosis and treatment by enabling earlier risk identification and personalized therapeutic approaches. Additionally, advancements in regenerative medicine, minimally invasive procedures, and next-generation cardiovascular therapies are creating new opportunities for improving patient outcomes.

As the cardiovascular health market continues to evolve, comprehensive market analysis provides valuable insights into emerging technologies, investment opportunities, research directions, and industry collaborations. The 16th World Heart Congress, taking place on March 18–19, 2027, in Paris, France, serves as a global platform for experts, organizations, and innovators to exchange knowledge, explore market developments, and contribute to the future advancement of cardiovascular medicine.